Alonso-Felipe, Miguel
Aguiar-Pérez, Javier Manuel
Pérez-Juárez, María Ángeles
Baladrón, Carlos
Peral-Oliveira, Julio
Amat-Santos, Ignacio J.
Funding for this research was provided by:
Gerencia Regional de Salud de Castilla y León (GRS 2275/A/2020, GRS 2275/A/2020, GRS 2275/A/2020, GRS 2275/A/2020, GRS 2275/A/2020, GRS 2275/A/2020)
Instituto de Salud Carlos III (DTS21/00158, DTS21/00158, DTS21/00158, DTS21/00158, DTS21/00158, DTS21/00158)
Universidad de Valladolid
Article History
Received: 28 November 2022
Revised: 12 July 2023
Accepted: 29 August 2023
First Online: 8 September 2023
Declarations
:
: The authors declare no competing interests.
: Approval for this study was obtained from the local ethics committee “Comité de Ética de la investigación con Medicamentos Área de Salud Valladolid Este” in Valladolid (Spain), at its meeting on February 18, 2021.
: The authors declare no competing interests.